当前位置:首页 - 行情中心 - 联盛化学(301212) - 财务分析 - 利润表

联盛化学

(301212)

  

流通市值:20.52亿  总市值:23.64亿
流通股本:9375.00万   总股本:1.08亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入577,671,219.77407,646,305.88186,333,437.69693,391,059.26
  营业收入577,671,219.77407,646,305.88186,333,437.69693,391,059.26
二、营业总成本562,950,725.01385,982,783.76177,992,271.4682,334,546.01
  营业成本496,656,165.96341,036,577.5156,154,683.43612,809,928.74
  税金及附加3,936,707.812,511,197.611,280,222.224,526,015.65
  销售费用7,419,700.84,873,415.032,060,295.429,091,486.23
  管理费用31,478,141.2321,018,045.5810,723,674.3933,131,710.58
  研发费用19,808,665.7714,196,925.536,572,073.7125,062,567.32
  财务费用3,651,343.442,346,622.511,201,322.23-2,287,162.51
  其中:利息费用87,109.0173,377.8546,230.01101,423.03
  其中:利息收入1,863,182.171,415,659.78341,832.384,921,324.11
三、其他经营收益
  加:公允价值变动收益-567,536.01-578,884.86-201,866.99-638,292.28
  加:投资收益74,488.68217,314.15188,267.191,353,167.55
  资产处置收益0--17,414.05
  资产减值损失(新)110,441.49-61,366.71-394,774.8353,407.78
  信用减值损失(新)587,390.46280,651.81-830,430.24991,245.69
  其他收益2,132,766.111,552,252.58856,742.494,903,077.68
四、营业利润17,058,045.4923,073,489.097,959,103.9117,736,533.72
  加:营业外收入119,433.6900.6900.6367,876.9
  减:营业外支出110,400.434,369.0213,166.34775,051
五、利润总额17,067,078.6923,040,020.677,946,838.1717,329,359.62
  减:所得税费用211,195.551,956,878.19837,988.18886,184.62
六、净利润16,855,883.1421,083,142.487,108,849.9916,443,175
(一)按经营持续性分类
  持续经营净利润16,855,883.1421,083,142.487,108,849.9916,443,175
(二)按所有权归属分类
  归属于母公司股东的净利润14,162,918.4919,026,460.776,091,187.5213,852,616.14
  少数股东损益2,692,964.652,056,681.711,017,662.472,590,558.86
  扣除非经常损益后的净利润14,055,703.6818,995,979.346,009,084.0811,371,614.03
七、每股收益
  (一)基本每股收益0.130.180.060.13
  (二)稀释每股收益0.130.180.060.13
九、综合收益总额16,855,883.1421,083,142.487,108,849.9916,443,175
  归属于母公司股东的综合收益总额14,162,918.4919,026,460.776,091,187.5213,852,616.14
  归属于少数股东的综合收益总额2,692,964.652,056,681.711,017,662.472,590,558.86
公告日期2026-10-292026-08-272026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑